Tina Q. Tan, MD - Easing the RSV Burden in Infants: Looking Ahead to New Prevention Strategies

episode

CME in Minutes: Education in Rheumatology, Immunology, & Infectious Diseases not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

NPR News: 09-24-2026 5AM EDT 5 min · 24 Sep 2026 · NPR News Now

Busting Brain Myths: TikTok's Viral Neuroscientist 11 min · 24 Sep 2026 · Today with David McCullagh

Classic Suze School: The Keys to a Successful Relationship 20 min · 24 Sep 2026 · Suze Orman's Women & Money (And Everyone Smart Enough To Listen)

Give Yourself a Year to Try 12 New Things and Embrace Change 39 min · 24 Sep 2026 · The Oprah Podcast

We Investigated the Christian "Scam" Fronted by Tim Tebow 1h 17m · 24 Sep 2026 · Pablo Torre Finds Out

Trump threatens Iran in fiery UN speech. What's next? 14 min · 24 Sep 2026 · The Excerpt

Report any issue

Source

Recorded27 Jun 2023

Publisherc.answersincme.com ↗

Handlerec:13096845

Show notes

Please visit answersincme.com/YXX860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in pediatrics discusses respiratory syncytial virus (RSV) vaccines for infants. Upon completion of this activity, participants should be better able to: Recognize the rationale for considering respiratory syncytial virus (RSV) vaccines for infants; Describe the clinical profiles of emerging long-acting monoclonal antibodies and maternal vaccines for preventing RSV in infants; and Outline strategies for optimal integration of emerging agents, including overcoming barriers to vaccination, for improving patient outcomes.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in